Three of the four non-executive directors for Neil Woodford’s forthcoming Patient Capital Trust have ties to Imperial College London’s tech transfer office Imperial Innovations.
The £200m ($309m) fund, due to be launched in April, will maintain a focus on tech startups and university spin-outs – a strategy underlined by Woodford’s non-executive director picks.
The board will be chaired by Susan Searle, former CEO of Imperial Innovations, who led the company through its IPO in 2006 up until moving on from…
